Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission
Report on planning meeting 1: Technical consultation on current status and planning for future development of genetically modified mosquitoes for malaria and dengue control
Summary
The use of genetically modified mosquitoes (GMMs) for disease control has social, economic and ethical implications, so it is important that the World Health Organization (WHO) and its partners provide guidance to countries on these issues. In collaboration with the Foundation for the National Institutes of Health (FNIH), TDR has developed a series of planning meetings on Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission. These technical and public consultations will focus on current status and planning for future development.